BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25503128)

  • 1. MAD2 expression in oral squamous cell carcinoma and its relationship to tumor grade and proliferation.
    Rizzardi C; Torelli L; Schneider M; Giudici F; Zandona L; Biasotto M; Di Lenarda R; Melato M
    Anticancer Res; 2014 Dec; 34(12):7021-7. PubMed ID: 25503128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic significance of BubR1 and Mad2 overexpression in oral cancer.
    Teixeira JH; Silva P; Faria J; Ferreira I; Duarte P; Delgado ML; Queirós O; Moreira R; Barbosa J; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
    Oral Dis; 2015 Sep; 21(6):713-20. PubMed ID: 25754611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival.
    Rizzardi C; Torelli L; Barresi E; Schneider M; Canzonieri V; Biasotto M; Di Lenarda R; Melato M
    Head Neck; 2011 May; 33(5):727-33. PubMed ID: 21069850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer.
    McGrogan B; Phelan S; Fitzpatrick P; Maguire A; Prencipe M; Brennan D; Doyle E; O'Grady A; Kay E; Furlong F; McCann A
    Hum Pathol; 2014 Jul; 45(7):1509-19. PubMed ID: 24792619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.
    Hsieh PC; Chen YK; Tsai KB; Shieh TY; Chang YY; Chang JG; Wu HL; Lin SF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):257-67. PubMed ID: 19926498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.
    Bargiela-Iparraguirre J; Prado-Marchal L; Pajuelo-Lozano N; Jiménez B; Perona R; Sánchez-Pérez I
    Cell Cycle; 2014; 13(22):3590-601. PubMed ID: 25483095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma.
    Lo Muzio L; Leonardi R; Mignogna MD; Pannone G; Rubini C; Pieramici T; Trevisiol L; Ferrari F; Serpico R; Testa N; De Rosa G; Staibano S
    Anticancer Res; 2004; 24(2C):1063-9. PubMed ID: 15154624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
    J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
    Usukura K; Kasamatsu A; Okamoto A; Kouzu Y; Higo M; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):123-30. PubMed ID: 22986808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry.
    Burum-Auensen E; De Angelis PM; Schjølberg AR; Kravik KL; Aure M; Clausen OP
    J Histochem Cytochem; 2007 May; 55(5):477-86. PubMed ID: 17242465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis.
    Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kouzu Y; Koike H; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H
    Hum Pathol; 2009 Jan; 40(1):83-91. PubMed ID: 18789482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous reduction of MAD2 and BUBR1 expression induces mitotic spindle alterations associated with p53 dependent cell cycle arrest and death.
    Lentini L; Piscitello D; Veneziano L; Di Leonardo A
    Cell Biol Int; 2014 Aug; 38(8):933-41. PubMed ID: 24687487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
    J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
    Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
    J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cell-cycle regulatory proteins BUBR1, MAD2, Aurora A, cyclin A and cyclin E in invasive ductal breast carcinomas.
    Du J; Du Q; Zhang Y; Sajdik C; Ruan Y; Tian XX; Fang WG
    Histol Histopathol; 2011 Jun; 26(6):761-8. PubMed ID: 21472690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.